Alsokam solution for infection. 10mg/ml amp. 1.5 ml No. 5

Solution for injections Alsokam is shown for short-term symptomatic treatment of a bad attack of a pseudorheumatism and an ankylosing spondylitis when peroral and other ways of use cannot be applied.

Structure

Active ingredient: to meloksika;

1.5 ml of solution;

1 ml of solution;

Excipients: Megluminum, glikofurol, half-oxameasures 188, sodium chloride, glycine, sodium hydroxide, water for injections.

Contraindication

• III pregnancy trimester;
• age of the patient up to 18 years;
• hypersensitivity to active ingredient or to other components of medicine;
• hypersensitivity to active agents with similar action, such as NPVP, aspirin. Patients who had asthma symptoms, nasal polyps, a Quincke's disease or a small tortoiseshell after intake of aspirin or other NPVP should not appoint Alsokam medicine;
• gastrointestinal bleeding or the perforation connected with the previous therapy of NPVP in the anamnesis;
• an active or recurrent round ulcer / bleeding in the anamnesis (two or more separate confirmed case of an ulcer or bleeding);
• heavy liver failure;
• a heavy renal failure without dialysis use;
• gastrointestinal bleeding, cerebrovascular bleeding in the anamnesis or other disturbances of blood clotting;
• disorder of a hemostasis or simultaneous use of anticoagulants (contraindications are connected with way of use);
• heavy heart failure.

to treatment of perioperatsionny pain at coronary shunting.

Route of administration

For intramuscular use.

by a deep intramuscular injection into an upper external quadrant of a buttock with observance of the strict aseptic equipment. In case of repeated introduction it is recommended to alternate the left and right buttocks. Before an injection it is important to check that the edge of a needle did not get to a vessel.

Injection should be stopped immediately in case of severe pain during an injection.

If the patient has a prosthesis of a hip joint, the injection should be made in other buttock.

should apply oral forms of medicament (tablet) To continuation of treatment.

Feature of use

Pregnant

during I and II trimester of pregnancy to meloksika should not be applied, except for emergency. For women who try to become pregnant and also for pregnant women throughout I and II trimester the dosage and duration of treatment meloksikamy have to be the smallest.

It is contraindicated during the III trimester of pregnancy.

Children

Alsokam, solution for injections, 10 mg/ml, is contraindicated to children (aged up to 18 years).

Drivers

Special researches concerning influence of medicine on ability to drive the car or to work with other mechanisms.

Overdose

Symptoms.

Symptoms of acute overdose of NPVP are usually limited to a lethargy, drowsiness, nausea, vomiting and epigastric pain which in general are reversible at maintenance therapy. There can be gastrointestinal bleeding. The serious poisoning can lead to arterial hypertension, an acute renal failure, liver dysfunction, respiratory depression, a coma, spasms, cardiovascular insufficiency and cardiac arrest. It was reported about anaphylactoid reactions at therapeutic use of NPVP that it can also be observed at overdose.

Therapy.

At overdose of NPVP to patients recommend the symptomatic and supporting actions. Researches showed that owing to use of 4 oral doses of a holestiramin 3 times a day occur the accelerated removal of a meloksikam.

Side effects

Majority of side effects which are observed, gastrointestinal origin. The round ulcer, perforation or gastrointestinal bleeding, sometimes lethal, especially at patients of advanced age is possible. After use of NPVP the nausea, vomiting, diarrhea, a meteorism, a constipation, dyspepsia, abdominal pain, a melena, vomiting by blood, a stomacace, exacerbation of colitis and Crohn's disease were observed. With a smaller frequency the gastritis was observed.

Interaction

Some medicines can promote a hyperpotassemia: potassium salts, kaliysberegayushchy diuretics, inhibitors of angiotensin-converting enzyme (APF), antagonists of receptors of angiotensin II, non-steroidal anti-inflammatory drugs, heparins (low-molecular or unfractionated), cyclosporine, takrolimus and Trimethoprimum.

Beginning of a hyperpotassemia can depend on whether there are related factors. The risk of emergence of a hyperpotassemia increases in case of the accompanying use of above-mentioned medicines and a meloksikam.

to Store

in original packing at a temperature not above 25 °C. To store out of children's reach.

Expiration date - 2 years.